StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Cizzle Biotechnology Holdings Plc
LSE:CIZ.L
Sector
Location
Market Cap
USD 8.50 M
Share Price
USD 0.02
Avg Daily Volume
1,267,282
Change (1 day)
3.17%
Change (1 year)
-21.08%
Change (YTD)
10.62%
Cizzle Biotechnology Holdings Plc Operating Income for the year ending December 31, 2022: USD -1.16 M
Cizzle Biotechnology Holdings Plc Operating Income is USD -1.16 M for the year ending December 31, 2022, a -138.12% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
-
Cizzle Biotechnology Holdings Plc Operating Income for the year ending December 31, 2021 was USD 3.05 M, a -830.57% change year over year.
-
Cizzle Biotechnology Holdings Plc Operating Income for the year ending December 31, 2020 was USD -417.88 K.
-
Cizzle Biotechnology Holdings Plc Operating Income for the year ending December 31, 2018 was USD -2.21 M, a -19.30% change year over year.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
MERCK Kommanditgesellschaft auf Aktien
USD 128.57
MRK.DE
-0.77
-0.59%
Agilent Technologies, Inc.
USD 113.99
A
-2.37
-2.04%
Qiagen N.V.
USD 48.36
QGEN
+0.12
0.25%
Aurobindo Pharma Limited
USD 13.22
AUROPHARMA.NS
-0.18
-1.37%
Yuhan Corporation
USD 94.38
000100.KS
-2.58
-2.66%
Repligen Corporation
USD 116.25
RGEN
-7.79
-6.28%
Bruker Corporation
USD 40.55
BRKR
-1.64
-3.89%
Pharmaron Beijing Co., Ltd.
USD 2.36
3759.HK
+0.01
0.45%
Bachem Holding AG
USD 72.50
BANB.SW
+0.43
0.60%
Siegfried Holding AG
USD 111.46
SFZN.SW
-0.15
-0.13%
Cohance Lifesciences Limited
USD 12.57
COHANCE.NS
-0.17
-1.34%
Gan & Lee Pharmaceuticals.
USD 8.19
603087.SS
+0.02
0.24%
Metsera, Inc.
USD 42.71
MTSR
-1.59
-3.59%
Bloomage BioTechnology Corporation Limited
USD 7.15
688363.SS
-0.03
-0.39%
Syngene International Limited
USD 7.63
SYNGENE.NS
-0.16
-2.05%
Jafron Biomedical Co.,Ltd.
USD 3.18
300529.SZ
+0.03
0.81%
Beijing Hotgen Biotech Co., Ltd.
USD 27.72
688068.SS
-0.14
-0.49%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.34
300009.SZ
-0.03
-2.33%
Changzhou Qianhong Biopharma CO.,LTD
USD 1.67
002550.SZ
+0.08
5.20%
Key Data
| Date | Operating Income | EBIT | EBITDA | Net Income |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
MERCK Kommanditgesellschaft auf Aktien
USD 128.57
MRK.DE
-0.77
-0.59%
Agilent Technologies, Inc.
USD 113.99
A
-2.37
-2.04%
Qiagen N.V.
USD 48.36
QGEN
+0.12
0.25%
Aurobindo Pharma Limited
USD 13.22
AUROPHARMA.NS
-0.18
-1.37%
Yuhan Corporation
USD 94.38
000100.KS
-2.58
-2.66%
Repligen Corporation
USD 116.25
RGEN
-7.79
-6.28%
Bruker Corporation
USD 40.55
BRKR
-1.64
-3.89%
Pharmaron Beijing Co., Ltd.
USD 2.36
3759.HK
+0.01
0.45%
Bachem Holding AG
USD 72.50
BANB.SW
+0.43
0.60%
Siegfried Holding AG
USD 111.46
SFZN.SW
-0.15
-0.13%
Cohance Lifesciences Limited
USD 12.57
COHANCE.NS
-0.17
-1.34%
Gan & Lee Pharmaceuticals.
USD 8.19
603087.SS
+0.02
0.24%
Metsera, Inc.
USD 42.71
MTSR
-1.59
-3.59%
Bloomage BioTechnology Corporation Limited
USD 7.15
688363.SS
-0.03
-0.39%
Syngene International Limited
USD 7.63
SYNGENE.NS
-0.16
-2.05%
Jafron Biomedical Co.,Ltd.
USD 3.18
300529.SZ
+0.03
0.81%
Beijing Hotgen Biotech Co., Ltd.
USD 27.72
688068.SS
-0.14
-0.49%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.34
300009.SZ
-0.03
-2.33%
Changzhou Qianhong Biopharma CO.,LTD
USD 1.67
002550.SZ
+0.08
5.20%